Gilbert R E, Goodall I, Young V, Jerums G
Endocrinology Unit, Austin and Repatriation Medical Centre, Heidelberg, Victoria, Australia.
Diabetes Care. 1996 Jul;19(7):730-4. doi: 10.2337/diacare.19.7.730.
To determine the extent of interlaboratory variation and accuracy in the measurement of glycated hemoglobin (GHb).
All laboratories that measure glycated hemoglobin in the State of Victoria, Australia, were invited to participate, and positive responses were received from 27 to 30 laboratories. An aliquot of blood drawn from three patients with diabetes and varied glycemia and from one nondiabetic subject was sent to each participating laboratory. Distribution of results was analyzed according to the reported results and their variance from an assigned reference value and were expressed as differing from this latter value as percentage bias and in absolute terms. A bias > or = 10% or an absolute difference of > or = 1% HbA1c from the reference value was considered significant.
Reported results for the same blood sample ranged from 4.1 to 5.8%, 5.1 to 8.2%, 6.7 to 9.3%, and 10.1 to 14.7% for the specimens from the nondiabetic subject and the diabetic patients with good, moderate, and poor glycemic control, respectively. The proportion of laboratories with results that differed by > or = 10% bias from the reference value were 39% (12 of 30), 29% (9 of 30), 16% (5 of 30), and 32% (10 of 30), and the proportion reporting results that differed by > or = 1% HbA1c in absolute terms from the reference values were 3% (1 of 30), 6% (2 of 30), 16% (5 of 30), and 23% (7 of 30) for the specimens from the nondiabetic subject and the diabetic patients with good, moderate, and poor glycemic control, respectively.
A substantial degree of interlaboratory variation for GHb measurement exists in Victoria, Australia. This may lead to difficulties in interpretation when GHb is assayed by different laboratories in the same patient over time. Interlaboratory standardization may be achievable by calibration to a standard assigned by a reference laboratory and distributed to all laboratories measuring GHb.
确定糖化血红蛋白(GHb)测量中实验室间差异的程度和准确性。
邀请澳大利亚维多利亚州所有测量糖化血红蛋白的实验室参与,共收到27至30个实验室的积极回应。从三名血糖水平各异的糖尿病患者和一名非糖尿病受试者采集的血液等分试样被送往每个参与实验室。根据报告结果及其与指定参考值的差异分析结果分布,并以相对于后者值的百分比偏差和绝对值表示差异。偏差≥10%或HbA1c与参考值的绝对差值≥1%被视为显著差异。
对于非糖尿病受试者以及血糖控制良好、中等和较差的糖尿病患者的标本,同一血样报告的结果分别为4.1%至5.8%、5.1%至8.2%、6.7%至9.3%和10.1%至14.7%。结果与参考值偏差≥10%的实验室比例分别为39%(30个中的12个)、29%(30个中的9个)、16%(30个中的5个)和32%(30个中的10个);结果与参考值的HbA1c绝对差值≥1%的实验室比例分别为3%(30个中的1个)、6%(30个中的2个)、16%(30个中的5个)和23%(30个中的7个),分别对应非糖尿病受试者以及血糖控制良好、中等和较差的糖尿病患者的标本。
在澳大利亚维多利亚州,糖化血红蛋白测量存在相当程度的实验室间差异。随着时间推移,当不同实验室对同一患者检测糖化血红蛋白时,这可能导致结果解读困难。通过校准参考实验室指定并分发给所有测量糖化血红蛋白的实验室的标准品,实验室间标准化或许可以实现。